Clinical Evidence: How Sucralfate Physically Shields Ulcers from Stomach Acid

An insightful review of Clinical Evidence: How Sucralfate Physically Shields Ulcers from Stomach Acid—uncover the main takeaways.

Sucralfate is a basic aluminum salt of sucrose octasulfate. When swallowed, it encounters the hydrochloric acid of the stomach. At a pH below 4.0, the drug undergoes an extensive polymerization process. The molecules cross-link, shedding their aluminum ions to form a sticky, negatively charged, water-insoluble gel.

This gel has an affinity for damaged tissue. Intact gastrointestinal mucosa is lined with a slick layer of protective mucus and neutral cell surfaces. In contrast, an ulcer crater or erosive lesion exposes raw submucosal proteins. Albumin, fibrinogen, and other positively charged tissue proteins lie exposed to the gastric lumen.

Because opposites attract at a molecular level, the negatively charged sucralfate polymer binds aggressively to these positively charged protein exudates. The resulting complex forms a physical barrier over the crater.

This barrier resists the mechanical wash of peristalsis and stands firm against digestive threats. It blocks free hydrochloric acid from burning deeper nerve endings, repels pepsin molecules to halt proteolytic digestion of the stomach wall, and prevents bile salts from dissolving cellular lipid membranes.

Beyond providing passive physical protection, sucralfate triggers active tissue repair. Lab studies demonstrate that the bound complex stimulates local mucosal prostaglandin production, which increases endogenous bicarbonate delivery to the injured tissue. It also concentrates basic fibroblast growth factor (bFGF) directly within the ulcer crater, accelerating epithelial migration and tissue regeneration.